Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy

Neuroradiology

Volumn 47, Issue 8, 2005, Pages 616-621

  Kim, Dong Joon ^a   Kim, Dong Ik ^a   Kim, Seo Hyun ^b   Lee, Kyung Yeol ^c   Heo, Ji Hoe ^a   Han, Sang Won ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University Wonju College of Medicine   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

Acute; Cerebral ischemia; Stroke; Therapy; Thrombolytic

Indexed keywords

ANTITHROMBOCYTIC AGENT; HEPARIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BARTHEL INDEX; BOLUS INJECTION; BRAIN RADIOGRAPHY; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG INFUSION; DRUG RESPONSE; FEASIBILITY STUDY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MORTALITY; PRIORITY JOURNAL; RANKIN SCALE; RECANALIZATION; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DRUG RESISTANCE; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; TREATMENT OUTCOME;

EID: 24344495263     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-005-1388-2     Document Type: Article

References (26)

1. The National Institute Of Neurological Disorders And Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 1581-1587
2. Christou I, Alexandrov AV, Burgin WS, Wojner AW, Felberg RA, Malkoff M, Grotta JC (2000) Timing of recanalization after tissue plasminogen activator therapy determined by transcranial doppler correlates with clinical recovery from ischemic stroke. Stroke 31 1812-1816 1:CAS:528:DC%2BD3cXlvFynsrY%3D
3. Alexandrov AV, Burgin WS, Demchuk AM, El-Mitwalli A, Grotta JC (2001) Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: Sonographic classification and short-term improvement. Circulation 103 2897-2902 1:CAS:528:DC%2BD3MXltlyjtr0%3D
4. Labiche LA, Al-Senani F, Wojner AW, Grotta JC, Malkoff M, Alexandrov AV (2003) Is the benefit of early recanalization sustained at 3 months? A prospective cohort study. Stroke 34 695-698 10.1161/ 01.STR.0000055940.00316.6B
5. Felberg RA, Okon NJ, El-Mitwalli A, Burgin WS, Grotta JC, Alexandrov AV (2002) Early dramatic recovery during intravenous tissue plasminogen activator infusion: Clinical pattern and outcome in acute middle cerebral artery stroke. Stroke 33 1301-1307 10.1161/ 01.STR.0000015556.48283.74
6. Molina CA, Alexandrov AV, Demchuk AM, Saqqur M, Uchino K, Alvarez-Sabin J (2004) Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 35 151-156 10.1161/01.STR.0000106485.04500.4A
7. Christou I, Burgin WS, Alexandrov AV, Grotta JC (2001) Arterial status after intravenous TPA therapy for ischaemic stroke. A need for further interventions. Int Angiol 20 208-213 1:STN:280:DC%2BD3MrisFGnuw%3D%3D
8. Alexandrov AV, Molina CA, Grotta JC, Garami Z, Ford SR, Alvarez-Sabin J, Montaner J, Saqqur M, Demchuk AM, Moye LA, Hill MD, Wojner AW (2004) Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke. N Engl J Med 351 2170-2178
9. TIMI Study Group (1985) The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings. N Engl J Med 312 932-936
10. Brott TG, Haley EC Jr, Levy DE, Barsan W, Broderick J, Sheppard GL, Spilker J, Kongable GL, Massey S, Reed R, et al (1992) Urgent therapy for stroke part I. Pilot study of tissue plasminogen activator administered within 90 min. Stroke 23 632-640 1:STN:280:By2B2MvitVc%3D
11. Zarich SW, Kowalchuk GJ, Weaver WD, Loscalzo J, Sassower M, Manzo K, Byrnes C, Muller JE, Gurewich V (1995) Sequential combination thrombolytic therapy for acute myocardial infarction: Results of the Pro-Urokinase and t-PA Enhancement of Thrombolysis (PATENT) Trial. J Am Coll Cardiol 26 374-379 10.1016/0735-1097(95)80009-6
12. Morris JA, Muller DW, Topol EJ (1991) Combination thrombolytic therapy: a comparison of simultaneous and sequential regimens of tissue plasminogen activator and urokinase. Am Heart J 122 375-380 10.1016/ 0002-8703(91)90988-T
13. Califf RM, Topol EJ, Stack RS, Ellis SG, George BS, Kereiakes DJ, Samaha JK, Worley SJ, Anderson JL, Harrelson-Woodlief L, et al (1991) Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction - phase five randomized trial. TAMI Study Group. Circulation 83 1543-1556 1:STN:280:By6B3MrnsVA%3D
14. Popma JJ, Califf RM, Ellis SG, George BS, Kereiakes DJ, Samaha JK, Worley SJ, Anderson JL, Stump D, Woodlief L, et al (1992) Mechanism of benefit of combination thrombolytic therapy for acute myocardial infarction: A quantitative angiographic and hematologic study. J Am Coll Cardiol 20 1305-1312 1:STN:280:ByyD2MrpvFU%3D
15. Topol EJ, Califf RM, George BS, Kereiakes DJ, Rothbaum D, Candela RJ, Abbotsmith CW, Pinkerton CA, Stump DC, Collen D, et al (1988) Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction. Circulation 77 1100-1107 1:STN:280:BieC1Mvps1Q%3D
16. Kidwell CS, Saver JL, Carneado J, Sayre J, Starkman S, Duckwiler G, Gobin YP, Jahan R, Vespa P, Villablanca JP, Liebeskind DS, Vinuela F (2002) Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 33 717-724 10.1161/hs0302.104110
17. Maksimenko AV, Tischenko EG (1999) New thrombolytic strategy: Bolus administration of tPA and urokinase - fibrinogen conjugate. J Thromb Thrombolysis 7 307-312 10.1023/A:1008939428688
18. Stachurska J, Latallo Z, Kopec M (1970) Inhibition of platelet aggregation by dialysable fibrinogen degradation products (FDP). Thromb Diath Haemorrh 23 91-98 1:CAS:528:DyaE3MXltFentA%3D%3D
19. Stump DC, Califf RM, Topol EJ, Sigmon K, Thornton D, Masek R, Anderson L, Collen D (1989) Pharmacodynamics of thrombolysis with recombinant tissue-type plasminogen activator. Correlation with characteristics of and clinical outcomes in patients with acute myocardial infarction. The TAMI Study Group. Circulation 80 1222-1230 1:STN:280:By%2BD3s%2FotVQ%3D
20. Ernst R, Pancioli A, Tomsick T, Kissela B, Woo D, Kanter D, Jauch E, Carrozzella J, Spilker J, Broderick J (2000) Combined intravenous and intra-arterial recombinant tissue plasminogen activator in acute ischemic stroke. Stroke 31 2552-2557 1:CAS:528:DC%2BD3cXosVaqsr0%3D
21. Keris V, Rudnicka S, Vorona V, Enina G, Tilgale B, Fricbergs J (2001) Combined intraarterial/intravenous thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 22 352-358 1:STN:280:DC%2BD3M3jtlKitQ%3D%3D
22. Suarez JI, Zaidat OO, Sunshine JL, Tarr R, Selman WR, Landis DM (2002) Endovascular administration after intravenous infusion of thrombolytic agents for the treatment of patients with acute ischemic strokes. Neurosurgery 50 251-260 10.1097/00006123-200202000-00005
23. Zaidat OO, Suarez JI, Santillan C, Sunshine JL, Tarr RW, Paras VH, Selman WR, Landis DM (2002) Response to intra-arterial and combined intravenous and intra-arterial thrombolytic therapy in patients with distal internal carotid artery occlusion. Stroke 33 1821-1826 10.1161/ 01.STR.0000020363.23725.67
24. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T (1999) Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency management of stroke (EMS) Bridging Trial. Stroke 30 2598-2605 1:CAS:528:DyaK1MXotFWkt74%3D
25. Hill MD, Barber PA, Demchuk AM, Newcommon NJ, Cole-Haskayne A, Ryckborst K, Sopher L, Button A, Hu W, Hudon ME, Morrish W, Frayne R, Sevick RJ, Buchan AM (2002) Acute intravenous - intra-arterial revascularization therapy for severe ischemic stroke. Stroke 33 279-282 10.1161/ hs0102.101900
26. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F (1999) Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282 2003-2011 10.1001/jama.282.21.2003